Main menu button

Actualités

Equity Research Kancera: Rights issue extends run-way at a crucial stage
05 Avr 2024
Equity Research Kancera: Rights issue extends run-way at a crucial stage
Equity Research Kancera
Carlsquare Equity Research: Biotech snapshot Q4
31 Jan 2024
Carlsquare Equity Research: Biotech snapshot Q4
Equity Research Kancera
Equity Research, Kancera: Focus on licensing
26 Jan 2024
Equity Research, Kancera: Focus on licensing
Equity Research Kancera
Equity Research Update Kancera, Q3 2023: Pending decisive outcome
04 Déc 2023
Equity Research Update Kancera, Q3 2023: Pending decisive outcome
Equity Research Kancera
Analyzing Nordic Biotech: News, Performance, Valuations, Big Pharma, Deals and Future Catalysts
31 Oct 2023
Analyzing Nordic Biotech: News, Performance, Valuations, Big Pharma, Deals and Future Catalysts
Equity Research Kancera
Carlsquare Equity Research: Nordic Life Science sector update
22 Sep 2023
Carlsquare Equity Research: Nordic Life Science sector update
Equity Research Kancera
Equity research update Kancera: Heart infarction results expected soon
22 Août 2023
Equity research update Kancera: Heart infarction results expected soon
Equity Research Kancera
Mrkt BUZZ, Kancera: Starting cancer trial
26 Avr 2023
Mrkt BUZZ, Kancera: Starting cancer trial
Equity Research Kancera
Research Update Kancera, Q4 2022: Start of cancer trial expected shortly
15 Mar 2023
Research Update Kancera, Q4 2022: Start of cancer trial expected shortly
Equity Research Kancera
Carlsquare Equity Research Nordic Life Science sector update
20 Fév 2023
Carlsquare Equity Research Nordic Life Science sector update
Equity Research Abera Bioscience
Mrkt BUZZ Kancera: Fractalkine project towards new milestones
03 Fév 2023
Mrkt BUZZ Kancera: Fractalkine project towards new milestones
Equity Research Kancera
Initiation of Coverage, Kancera: Expands the clinical program
24 Oct 2022
Initiation of Coverage, Kancera: Expands the clinical program
Equity Research Kancera